Simulations Plus Clears HSR Waiting Period For Altaris Acquisition, Closing Expected In H2 2026
Simulations Plus, Inc. (NASDAQ:SLP) ("Simulations Plus" or the "Company"), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, announced the
Read original at benzinga